Matches in SemOpenAlex for { <https://semopenalex.org/work/W2413009377> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W2413009377 endingPage "9" @default.
- W2413009377 startingPage "1325" @default.
- W2413009377 abstract "Pulmonary fibrosis, a frequent manifestation of systemic sclerosis (SSc), is considered incurable. Our aim was to assess the effect of therapy with intravenous (i.v.) cyclophosphamide on the course of pulmonary fibrosis in patients with SSc.Five patients with SSc and clinical, laboratory, or radiographic findings of interstitial lung disease were treated with cyclophosphamide (1 g) administered i.v. monthly for 48 weeks. The dyspnea score, pulmonary function tests, arterial blood oxygen content, radiologic abnormalities, and bronchoalveolar lavage (BAL) fluid cellularity were determined before and after therapy.The dyspnea score decreased by 42% after 48 weeks of therapy. Forced vital capacity (FVC, percentage of predicted) increased by 7%, and carbon monoxide diffusing capacity (DLCO) decreased by 12%, but these changes were not statistically significant. Arterial blood oxygenation remained unchanged. At baseline, high resolution computed tomography of the lungs showed honeycombing, reticulonodular, or ground glass patterns in each patient examined. These radiologic abnormalities did not improve during treatment. A marked decrease in BAL fluid cell number, but not in the percentage of neutrophils, was observed after therapy. Nausea and leukopenia were frequent but mild side effects. One patient developed hemorrhagic cystitis.The results suggest that intermittent treatment with i.v. cyclophosphamide reduces the severity of dyspnea, but fails to improve FVC or DLCO, or cause resolution of radiologic abnormalities, in patients with SSc." @default.
- W2413009377 created "2016-06-24" @default.
- W2413009377 creator A5000993126 @default.
- W2413009377 creator A5009896540 @default.
- W2413009377 creator A5012966437 @default.
- W2413009377 creator A5019918148 @default.
- W2413009377 creator A5042935310 @default.
- W2413009377 date "1998-07-01" @default.
- W2413009377 modified "2023-09-23" @default.
- W2413009377 title "A pilot study of intermittent intravenous cyclophosphamide for the treatment of systemic sclerosis associated lung disease." @default.
- W2413009377 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9676764" @default.
- W2413009377 hasPublicationYear "1998" @default.
- W2413009377 type Work @default.
- W2413009377 sameAs 2413009377 @default.
- W2413009377 citedByCount "29" @default.
- W2413009377 countsByYear W24130093772015 @default.
- W2413009377 countsByYear W24130093772016 @default.
- W2413009377 countsByYear W24130093772018 @default.
- W2413009377 countsByYear W24130093772020 @default.
- W2413009377 countsByYear W24130093772022 @default.
- W2413009377 crossrefType "journal-article" @default.
- W2413009377 hasAuthorship W2413009377A5000993126 @default.
- W2413009377 hasAuthorship W2413009377A5009896540 @default.
- W2413009377 hasAuthorship W2413009377A5012966437 @default.
- W2413009377 hasAuthorship W2413009377A5019918148 @default.
- W2413009377 hasAuthorship W2413009377A5042935310 @default.
- W2413009377 hasConcept C126322002 @default.
- W2413009377 hasConcept C16020263 @default.
- W2413009377 hasConcept C165637977 @default.
- W2413009377 hasConcept C27101514 @default.
- W2413009377 hasConcept C2776694085 @default.
- W2413009377 hasConcept C2776755627 @default.
- W2413009377 hasConcept C2777543607 @default.
- W2413009377 hasConcept C2777714996 @default.
- W2413009377 hasConcept C2777961210 @default.
- W2413009377 hasConcept C2778341716 @default.
- W2413009377 hasConcept C2779412668 @default.
- W2413009377 hasConcept C2780873365 @default.
- W2413009377 hasConcept C2781244666 @default.
- W2413009377 hasConcept C3018587741 @default.
- W2413009377 hasConcept C55520419 @default.
- W2413009377 hasConcept C71924100 @default.
- W2413009377 hasConcept C75603125 @default.
- W2413009377 hasConcept C90924648 @default.
- W2413009377 hasConceptScore W2413009377C126322002 @default.
- W2413009377 hasConceptScore W2413009377C16020263 @default.
- W2413009377 hasConceptScore W2413009377C165637977 @default.
- W2413009377 hasConceptScore W2413009377C27101514 @default.
- W2413009377 hasConceptScore W2413009377C2776694085 @default.
- W2413009377 hasConceptScore W2413009377C2776755627 @default.
- W2413009377 hasConceptScore W2413009377C2777543607 @default.
- W2413009377 hasConceptScore W2413009377C2777714996 @default.
- W2413009377 hasConceptScore W2413009377C2777961210 @default.
- W2413009377 hasConceptScore W2413009377C2778341716 @default.
- W2413009377 hasConceptScore W2413009377C2779412668 @default.
- W2413009377 hasConceptScore W2413009377C2780873365 @default.
- W2413009377 hasConceptScore W2413009377C2781244666 @default.
- W2413009377 hasConceptScore W2413009377C3018587741 @default.
- W2413009377 hasConceptScore W2413009377C55520419 @default.
- W2413009377 hasConceptScore W2413009377C71924100 @default.
- W2413009377 hasConceptScore W2413009377C75603125 @default.
- W2413009377 hasConceptScore W2413009377C90924648 @default.
- W2413009377 hasIssue "7" @default.
- W2413009377 hasLocation W24130093771 @default.
- W2413009377 hasOpenAccess W2413009377 @default.
- W2413009377 hasPrimaryLocation W24130093771 @default.
- W2413009377 hasRelatedWork W2080955906 @default.
- W2413009377 hasRelatedWork W2127353573 @default.
- W2413009377 hasRelatedWork W2129736170 @default.
- W2413009377 hasRelatedWork W2162403137 @default.
- W2413009377 hasRelatedWork W2183001831 @default.
- W2413009377 hasRelatedWork W2312508100 @default.
- W2413009377 hasRelatedWork W2413009377 @default.
- W2413009377 hasRelatedWork W2891210738 @default.
- W2413009377 hasRelatedWork W3166276505 @default.
- W2413009377 hasRelatedWork W4220786974 @default.
- W2413009377 hasVolume "25" @default.
- W2413009377 isParatext "false" @default.
- W2413009377 isRetracted "false" @default.
- W2413009377 magId "2413009377" @default.
- W2413009377 workType "article" @default.